A Protective Role for Arachidonic Acid Metabolites against Advanced Colorectal Adenoma in a Phase III Trial of Selenium
- PMID: 34836131
- PMCID: PMC8621008
- DOI: 10.3390/nu13113877
A Protective Role for Arachidonic Acid Metabolites against Advanced Colorectal Adenoma in a Phase III Trial of Selenium
Abstract
Oxylipins derived from arachidonic acid (ARA) have been implicated in the development of colorectal adenomas and colorectal cancer. The primary purpose of this work was to determine the relationship between plasma levels of oxylipins and colorectal adenoma characteristics at study entry, as well as with the development of a new adenoma during follow-up within a Phase III adenoma prevention clinical trial with selenium (Sel). Secondarily, we sought to determine whether the selenium intervention influenced plasma oxylipin levels. Four oxylipins were quantified in stored plasma samples from a subset of Sel study subjects (n = 256) at baseline and at 12-months. There were significantly lower odds of an advanced adenoma at baseline with higher prostaglandin E2 (PGE2), with an OR (95% CI) of 0.55 (0.33-0.92), and with 5-hydroxyeicosatetraenoic acid (5-HETE) ((0.53 (0.33-0.94)); and of a large adenoma with higher PGE2 ((0.52 (0.31-0.87)). In contrast, no associations were observed between any oxylipin and the development of a new adenoma during follow-up. Selenium supplementation was associated with a significantly smaller increase in 5-HETE after 12 months compared to the placebo, though no other results were statistically significant. The ARA-derived oxylipins may have a role in the progression of non-advanced adenoma to advanced, but not with the development of a new adenoma.
Keywords: ARA; arachidonic acid; colon cancer; colorectal adenoma; colorectal neoplasia; oxylipins; selenium.
Conflict of interest statement
The authors have no conflict of interest to declare.
Figures

Similar articles
-
Celecoxib use and circulating oxylipins in a colon polyp prevention trial.PLoS One. 2018 Apr 26;13(4):e0196398. doi: 10.1371/journal.pone.0196398. eCollection 2018. PLoS One. 2018. PMID: 29698447 Free PMC article. Clinical Trial.
-
Selenium Supplementation for Prevention of Colorectal Adenomas and Risk of Associated Type 2 Diabetes.J Natl Cancer Inst. 2016 Aug 16;108(12):djw152. doi: 10.1093/jnci/djw152. Print 2016 Dec. J Natl Cancer Inst. 2016. PMID: 27530657 Free PMC article. Clinical Trial.
-
Design and baseline characteristics of participants in a phase III randomized trial of celecoxib and selenium for colorectal adenoma prevention.Cancer Prev Res (Phila). 2012 Dec;5(12):1381-93. doi: 10.1158/1940-6207.CAPR-12-0204. Epub 2012 Oct 11. Cancer Prev Res (Phila). 2012. PMID: 23060037 Free PMC article. Clinical Trial.
-
Can selenium prevent colorectal cancer? A signpost from epidemiology.J Natl Cancer Inst. 2004 Nov 17;96(22):1645-7. doi: 10.1093/jnci/djh332. J Natl Cancer Inst. 2004. PMID: 15547171 Review. No abstract available.
-
Harnessing Oxylipins and Inflammation Modulation for Prevention and Treatment of Colorectal Cancer.Int J Mol Sci. 2024 May 15;25(10):5408. doi: 10.3390/ijms25105408. Int J Mol Sci. 2024. PMID: 38791445 Free PMC article. Review.
Cited by
-
Arachidonic acid metabolism in health and disease.MedComm (2020). 2023 Sep 20;4(5):e363. doi: 10.1002/mco2.363. eCollection 2023 Oct. MedComm (2020). 2023. PMID: 37746665 Free PMC article. Review.
-
Metabolomic analysis reveals key changes in amino acid metabolism in colorectal cancer patients.Amino Acids. 2025 May 2;57(1):22. doi: 10.1007/s00726-025-03448-3. Amino Acids. 2025. PMID: 40314699 Free PMC article.
-
The prognostic value of arachidonic acid metabolism in breast cancer by integrated bioinformatics.Lipids Health Dis. 2022 Oct 15;21(1):103. doi: 10.1186/s12944-022-01713-y. Lipids Health Dis. 2022. PMID: 36243728 Free PMC article.
-
Evaluation of Selenium Concentrations in Patients with Crohn's Disease and Ulcerative Colitis.Biomedicines. 2024 Sep 24;12(10):2167. doi: 10.3390/biomedicines12102167. Biomedicines. 2024. PMID: 39457481 Free PMC article.
-
Multi-omics analysis reveals that linoleic acid metabolism is associated with variations of trained immunity induced by distinct BCG strains.Sci Adv. 2024 Apr 5;10(14):eadk8093. doi: 10.1126/sciadv.adk8093. Epub 2024 Apr 5. Sci Adv. 2024. PMID: 38578989 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical